Mihir Joshi , Ameet S. Nagpal , Clark C. Smith , Byron J. Schneider
{"title":"International Pain and Spine Intervention Society Emergency Protocols: Vasovagal Reactions","authors":"Mihir Joshi , Ameet S. Nagpal , Clark C. Smith , Byron J. Schneider","doi":"10.1016/j.inpm.2026.100795","DOIUrl":"10.1016/j.inpm.2026.100795","url":null,"abstract":"<div><div>This protocol addresses vasovagal reactions, one of the most common adverse events encountered during interventional pain procedures. Symptoms range from diaphoresis, nausea, and lightheadedness to profound bradycardia, hypotension, syncope, or cardiovascular collapse. Management includes immediate cessation of the triggering stimulus, supportive positioning, monitoring of vital signs, initiation of Basic Life Support/Advanced Cardiovascular Life Support when necessary, and prevention strategies for high-risk patients.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100795"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148184422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Qing Zhao Ruan , Alexandra Fogarty , Belinda Duszynski , Christopher L. Robinson
{"title":"Utilization and perceptions of artificial intelligence in pain medicine practice: An international pain and spine intervention society survey-based analysis","authors":"Qing Zhao Ruan , Alexandra Fogarty , Belinda Duszynski , Christopher L. Robinson","doi":"10.1016/j.inpm.2026.100797","DOIUrl":"10.1016/j.inpm.2026.100797","url":null,"abstract":"<div><h3>Background</h3><div>Artificial intelligence (AI) is rapidly expanding with Pain medicine, offering applications ranging from clinical documentation to predictive modeling. In view of this growing interest, the characteristics and sentiments of physician AI users in this field ought to be better delineated.</div></div><div><h3>Objectives</h3><div>To characterize the demographics of AI users in Pain medicine and evaluate patterns of adoption, utilization and attitudes towards AI integration in the clinical practice of Pain medicine.</div></div><div><h3>Methods</h3><div>A web-based survey was distributed via email and social media to US and international clinicians. Survey design was validated by the IPSIS AI Task Force and deemed IRB-exempt. Responses were analyzed descriptively.</div></div><div><h3>Results</h3><div>Respondents were predominantly male (83.9%) and most commonly anesthesiologists (35.7%) or PM&R physicians (48.2%), with over 60% in practice >10 years. AI familiarity was high, with 75% reporting clinical use and 51% using AI daily. Common applications included ambient documentation (60.8%) and research summarization (56.9%). Most users reported positive impact, particularly in time savings (80%). Key concerns included overreliance (38%), misinformation (38%), and legal liability (32%). Over 80% anticipated increased AI use within 2 years.</div></div><div><h3>Conclusions</h3><div>AI adoption among Pain physicians is significant and viewed favorably, though primarily applied to non-specialty-specific tasks. Addressing concerns and enhancing integration and education will be critical for advancing specialty-specific AI utilization.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100797"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148231319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stephan Klessinger , Fred DeFrancesch , Nathaniel M. Schuster
{"title":"International Pain and Spine Intervention Society Emergency Protocols: Traumatic Spinal Cord Injury","authors":"Stephan Klessinger , Fred DeFrancesch , Nathaniel M. Schuster","doi":"10.1016/j.inpm.2026.100790","DOIUrl":"10.1016/j.inpm.2026.100790","url":null,"abstract":"<div><div>This protocol reviews the causes, recognition, and emergency response to traumatic spinal cord injury during interventional spine procedures. Potential mechanisms include direct needle trauma, intramedullary injection, hematoma formation, and vascular injury. The protocol highlights the importance of immediate termination of the procedure, airway and hemodynamic stabilization, focused neurologic assessment, urgent activation of emergency services, and rapid transfer to a facility with neurosurgical capabilities.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100790"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148184424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jan van den Brink, Daniël P.C. van der Spek, Camiel J. Lalmohamed, Frank J.P.M. Huygen, Maaike Dirckx
{"title":"Thoracic sympathetic block with botulinum toxin A for complex regional pain syndrome: a retrospective case series","authors":"Jan van den Brink, Daniël P.C. van der Spek, Camiel J. Lalmohamed, Frank J.P.M. Huygen, Maaike Dirckx","doi":"10.1016/j.inpm.2026.100774","DOIUrl":"10.1016/j.inpm.2026.100774","url":null,"abstract":"<div><h3>Background</h3><div>Sympathetic interventions are frequently used in complex regional pain syndrome (CRPS). However, the evidence is inconclusive, and the response may depend on phenotype, anatomical target, and treatment durability. For upper-extremity CRPS, clinical data on thoracic sympathetic block (TSB) with botulinum toxin type A (BoNT-A) are lacking.</div></div><div><h3>Objective</h3><div>To describe patient characteristics, procedural details, and clinical and thermographic outcomes after computed tomography (CT)-guided TSB with BoNT-A in upper-extremity CRPS.</div></div><div><h3>Methods</h3><div>We performed a retrospective single-center case series of consecutive adults with upper-extremity CRPS who underwent CT-guided TSB with BoNT-A between January 2023 and March 2026. For each procedure, medical records were reviewed to descriptively assess pain change, duration of effect, repeat procedures, thermographic change, and adverse events.</div></div><div><h3>Results</h3><div>Six patients underwent 7 procedures. Most suffered from persistent, treatment-refractory CRPS. Responses varied: 3 patients experienced a clinically meaningful analgesic benefit, 1 had thermographic improvement without clear analgesic benefit, and 2 had no meaningful response. No serious procedure-related complications were observed.</div></div><div><h3>Conclusion</h3><div>CT-guided TSB with BoNT-A was feasible in this small retrospective series of refractory upper-extremity CRPS. Responses were heterogeneous, and thermographic improvement was not always accompanied by pain relief. The findings may prompt hypotheses regarding phenotype-based patient selection and the role of thermography.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100774"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148159589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sean Li , Zachary L. McCormick , Denise D. Lester , Michael J. DePalma , Christopher A. Gilmore , Jessica B. Jameson , Mehul J. Desai , Tristan E. Weaver , Shivanand P. Lad , Scott J. Davidoff , Drew M. Trainor , Kasra Amirdelfan , Mitchell P. Engle , Timothy R. Deer , Thomas S. Lee , Francesco Vetri , Meenakshi Bindal , Melissa A. Tornero-Bold , Morad N. Nasseri , Steven P. Cohen , Joseph W. Boggs
{"title":"Observations from the RESET clinical trial: A post-hoc per protocol analysis of clinical outcomes with percutaneous 60-day medial branch PNS in chronic low back pain","authors":"Sean Li , Zachary L. McCormick , Denise D. Lester , Michael J. DePalma , Christopher A. Gilmore , Jessica B. Jameson , Mehul J. Desai , Tristan E. Weaver , Shivanand P. Lad , Scott J. Davidoff , Drew M. Trainor , Kasra Amirdelfan , Mitchell P. Engle , Timothy R. Deer , Thomas S. Lee , Francesco Vetri , Meenakshi Bindal , Melissa A. Tornero-Bold , Morad N. Nasseri , Steven P. Cohen , Joseph W. Boggs","doi":"10.1016/j.inpm.2026.100775","DOIUrl":"10.1016/j.inpm.2026.100775","url":null,"abstract":"<div><h3>Background</h3><div>Percutaneous 60-day peripheral nerve stimulation (PNS) of the lumbar medial branches is a minimally invasive treatment option for chronic low back pain (CLBP). A recent randomized controlled trial (RESET Clinical Trial) met its primary endpoint, with a significantly greater proportion of participants treated with 60-day PNS (n = 112) reporting ≥50% reductions in average low back pain compared to those treated with physician-directed usual care with standard interventional management (n = 110; e.g., ablations, injections, physical therapy) at 3 months post start of treatment.</div></div><div><h3>Objective</h3><div>Building on the published findings from the Full Analysis Set, this post-hoc analysis primarily explored whether per protocol treatment delivery (bilateral stimulation that generated sensations covering the majority of the painful region in the low back for 6-12 h per day) was associated with response to 60-day PNS. Additional post-hoc evaluations explored the influence of clinical variables across the study population and investigated outcomes within exploratory subgroups of common clinical pain profiles (e.g.<em>,</em> patients with characteristics typical of facetogenic and discovertebral pain).</div></div><div><h3>Methods</h3><div>Univariate logistic regressions evaluated associations between variables (treatment delivery and clinical variables) and responder rate (≥50% reduction in average pain at 3 months).</div></div><div><h3>Results</h3><div>The results suggest per protocol treatment delivery is associated with positive outcomes following treatment with 60-day PNS for CLBP (odds ratio = 3.04, 95% confidence interval = [1.16, 7.93], p = 0.023). Within this clinical trial's population as defined by the inclusion and exclusion criteria, neither clinical variables (e.g., age, pain duration, gender, average pain intensity, pain interference, and disability) nor response to a medial branch block had a significant impact on treatment response. Additional post-hoc analyses showed positive outcomes with 60-day PNS among exploratory cohorts defined by common facetogenic and discovertebral pain features. Reductions in pain extended to improvements in pain interference and disability, with benefits sustained at all completed timepoints through 6 months (follow-up beyond 6 months is ongoing).</div></div><div><h3>Conclusions</h3><div>Together, these findings suggest that 60-day PNS treatment delivery is an important determinant of outcomes, underscoring the role of proper lead implantation, patient education, and treatment adherence in clinical practice.</div></div><div><h3>ClinicalTrials gov identifier</h3><div>NCT04246281.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100775"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148231321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clark C. Smith , Ryan M. Meral , Ronald A. Wasserman
{"title":"International Pain and Spine Intervention Society emergency protocols: Allergic and anaphylactic reactions","authors":"Clark C. Smith , Ryan M. Meral , Ronald A. Wasserman","doi":"10.1016/j.inpm.2026.100796","DOIUrl":"10.1016/j.inpm.2026.100796","url":null,"abstract":"<div><div>This protocol reviews the recognition and management of allergic reactions and anaphylaxis during interventional pain procedures. It describes the spectrum of hypersensitivity reactions, ranging from mild dermatologic symptoms to life-threatening multisystem anaphylaxis with airway compromise and cardiovascular collapse. Emphasis is placed on early recognition, immediate epinephrine administration, airway stabilization, intravenous fluid resuscitation, and transfer to higher-level care.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100796"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148231357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Charles A. Odonkor , Muhammad Uzair Siddique , Mustafa Reha Dodurgali , Sarvesh Palaniappan , Cameron Harris , Selaiman Noori , Jack Diep , Jared Rosenberg , Sudhir K. Kadian , Mannat Kadian , David W. Lee , Brian Durkin , Peter G. Whang
{"title":"Early pain-response trajectories after basivertebral nerve ablation and their relationship to 12-month clinical outcomes","authors":"Charles A. Odonkor , Muhammad Uzair Siddique , Mustafa Reha Dodurgali , Sarvesh Palaniappan , Cameron Harris , Selaiman Noori , Jack Diep , Jared Rosenberg , Sudhir K. Kadian , Mannat Kadian , David W. Lee , Brian Durkin , Peter G. Whang","doi":"10.1016/j.inpm.2026.100799","DOIUrl":"10.1016/j.inpm.2026.100799","url":null,"abstract":"<div><h3>Background</h3><div>Basivertebral nerve ablation (BVNA) is an established treatment for vertebrogenic low back pain, but the relationship between early post-procedural response and longer-term outcomes remains unclear.</div></div><div><h3>Objective</h3><div>To evaluate whether early pain-response trajectories following BVNA were associated with 12-month clinical outcomes and to identify a clinically useful time point for reassessment.</div></div><div><h3>Methods</h3><div>This prospective multicenter observational cohort study included 140 patients with MRI-confirmed Modic type 1 or 2 changes treated with BVNA between April 2024 and April 2025. Patients reported weekly percent pain relief through 8 weeks, followed by assessments at 3, 6, and 12 months. The primary outcome was ≥50% pain relief at 12 months. Discriminative performance of Week 3 and Week 6 responses was assessed using sensitivity, specificity, likelihood ratios, and receiver operating characteristic analysis. Time to first ≥50% relief was evaluated using Kaplan–Meier methods. Secondary outcomes included changes in Numeric Rating Scale (NRS), Oswestry Disability Index (ODI), Patient Global Impression of Change (PGIC), and post-procedural healthcare utilization.</div></div><div><h3>Results</h3><div>At 12 months, 82.1% achieved ≥50% pain relief. The mean NRS improved by 4.3 points and the mean ODI improved by 34 points, with 84.3% and 94.3% achieving Minimally Clinically Important Difference (MCID) thresholds, respectively. The Week 3 response was linked to increased likelihood of 12-month success (LR<sup>+</sup> 2.13; LR<sup>−</sup> 0.25). Discrimination of long-term outcomes was greater at Week 6 when analyzed continuously (AUC 0.96), with an optimal threshold of approximately 38% pain relief. All patients who achieved ≥30% pain relief by Week 6 also achieved clinically meaningful improvement at 12 months, whereas only 50% of those without early improvement achieved this threshold<strong>.</strong> Most 12-month responders achieved ≥50% relief within 4–6 weeks. Early improvement also corresponded to greater functional recovery and reduced subsequent spine-related interventions.</div></div><div><h3>Conclusion</h3><div>Early pain-response trajectories following BVNA were associated with 12-month outcomes. Clinically meaningful submaximal improvement (≥30%) identified patients who attained durable benefit, whereas absence of early improvement was linked to a lower likelihood of long-term success. These findings suggest that meaningful response signals may emerge before conventional ≥50% responder thresholds are reached, providing a more nuanced framework for interpreting early post-procedural response.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100799"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148231217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ryan M. Meral , Ameet S. Nagpal , Ronald Wasserman
{"title":"International Pain and Spine Intervention Society Emergency Protocols: Local Anesthetic Systemic Toxicity (LAST)","authors":"Ryan M. Meral , Ameet S. Nagpal , Ronald Wasserman","doi":"10.1016/j.inpm.2026.100778","DOIUrl":"10.1016/j.inpm.2026.100778","url":null,"abstract":"<div><div>This protocol outlines the pathophysiology, recognition, and treatment of Local Anesthetic Systemic Toxicity (LAST), a rare but life-threatening complication caused by excessive systemic absorption or intravascular injection of local anesthetics. Clinical manifestations may include seizures, arrhythmias, and cardiovascular collapse. The protocol emphasizes rapid identification, lipid emulsion therapy, airway management, seizure control, and modified Advanced Cardiovascular Life Support measures.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100778"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148231358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ameet S. Nagpal , Stephan Klessinger , Patrick H. Waring , Byron J. Schneider
{"title":"International Pain and Spine Intervention Society Emergency Protocols: Intradural or Intrathecal Local Anesthetic Injection","authors":"Ameet S. Nagpal , Stephan Klessinger , Patrick H. Waring , Byron J. Schneider","doi":"10.1016/j.inpm.2026.100791","DOIUrl":"10.1016/j.inpm.2026.100791","url":null,"abstract":"<div><div>This protocol reviews unintentional intradural or intrathecal injection during epidural procedures and the potentially serious neurologic and cardiopulmonary consequences that may result. It explains the importance of recognizing abnormal contrast flow patterns and using multiplanar fluoroscopic imaging to avoid inadvertent needle placement and/or anesthetic administration. Emergency management includes stopping the procedure, initiating airway and cardiovascular support as needed, neurologic monitoring, and prolonged observation until the anesthetic effects resolve.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100791"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148184427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}